Trials / Recruiting
RecruitingNCT06611020
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia
The Role of Adjuvant VaccInation After Conization for the Treatment for Cervical Dysplasia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions
Detailed description
Patients treated for HPV-related disease are counseled about the potential protective role of HPV vaccination. The investigators will monitor the risk of HPV recurrence in pateints who choce to have vaccination and who did not.
Conditions
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2025-01-31
- Completion
- 2027-01-31
- First posted
- 2024-09-24
- Last updated
- 2024-09-26
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06611020. Inclusion in this directory is not an endorsement.